Histamine-2-receptor antagonists and gastric cancer risk
- 11 August 1990
- journal article
- Published by Elsevier in The Lancet
- Vol. 336 (8711) , 355-357
- https://doi.org/10.1016/0140-6736(90)91888-h
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- A case‐control study of diet and gastric cancer in Northern ItalyInternational Journal of Cancer, 1987
- Postmarketing surveillance of the safety of cimetidine: mortality during second, third, and fourth years of follow up.BMJ, 1985
- Antisecretory drugs and gastric cancer.BMJ, 1985
- Postmarketing surveillance of the safety of cimetidine: 12 month mortality report.BMJ, 1983
- Cimetidine and gastric cancer: preliminary report from post-marketing surveillance study.BMJ, 1982
- GASTRIC CANCER AND CIMETIDINE: DOES DELAY IN DIAGNOSIS MATTER?The Lancet, 1981
- SUCCESSFUL TUMOUR IMMUNOTHERAPY WITH CIMETIDINE IN MICEThe Lancet, 1981
- GASTRIC CANCER AFTER CIMETIDINE IN PATIENT WITH TWO NEGATIVE PRE-TREATMENT BIOPSIESThe Lancet, 1980
- GASTRIC CANCER IN PATIENTS WHO HAVE TAKEN CIMETIDINEThe Lancet, 1979
- CIMETIDINE AND GASTRIC CANCERThe Lancet, 1979